453 related articles for article (PubMed ID: 27376790)
1. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
[TBL] [Abstract][Full Text] [Related]
2. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
3. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
4. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
6. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy.
Kopac P; Rudin M; Gentinetta T; Gerber R; Pichler Ch; Hausmann O; Schnyder B; Pichler WJ
Allergy; 2012 Feb; 67(2):280-5. PubMed ID: 22070352
[TBL] [Abstract][Full Text] [Related]
7. Birch-apple syndrome treated with birch pollen immunotherapy.
Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G
Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831
[TBL] [Abstract][Full Text] [Related]
8. Allergen immunotherapy for birch-apple syndrome: what do we know?
Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E
Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794
[TBL] [Abstract][Full Text] [Related]
9. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Kopp S; Wolkersdorfer M; Bohle B
Allergy; 2016 Feb; 71(2):272-4. PubMed ID: 26443126
[TBL] [Abstract][Full Text] [Related]
12. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy.
van der Valk JPM; Nagl B; van Wljk RG; Bohle B; de Jong NW
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085633
[TBL] [Abstract][Full Text] [Related]
14. Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells.
Fritsch R; Bohle B; Vollmann U; Wiedermann U; Jahn-Schmid B; Krebitz M; Breiteneder H; Kraft D; Ebner C
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):679-86. PubMed ID: 9802379
[TBL] [Abstract][Full Text] [Related]
15. Food allergy to apple and specific immunotherapy with birch pollen.
Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
[TBL] [Abstract][Full Text] [Related]
16. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
[TBL] [Abstract][Full Text] [Related]
17. Allergy to apple cultivars among patients with birch pollinosis and oral allergy syndrome.
Wagner A; Szwed A; Buczyłko K; Wagner W
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):399-404. PubMed ID: 27593099
[TBL] [Abstract][Full Text] [Related]
18. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis.
Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ
Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127
[TBL] [Abstract][Full Text] [Related]
19. Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1- related PR-10 protein in soybean, SAM22.
Kleine-Tebbe J; Vogel L; Crowell DN; Haustein UF; Vieths S
J Allergy Clin Immunol; 2002 Nov; 110(5):797-804. PubMed ID: 12417891
[TBL] [Abstract][Full Text] [Related]
20.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
